IRIS Accounts Production v25.4.0.155 03958441 director 31.3.24 30.3.25 30.3.25 false true false false false true false Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh039584412024-03-30039584412025-03-30039584412024-03-312025-03-30039584412023-03-30039584412023-03-312024-03-30039584412024-03-3003958441ns15:EnglandWales2024-03-312025-03-3003958441ns14:PoundSterling2024-03-312025-03-3003958441ns10:Director12024-03-312025-03-3003958441ns10:PrivateLimitedCompanyLtd2024-03-312025-03-3003958441ns10:SmallEntities2024-03-312025-03-3003958441ns10:AuditExempt-NoAccountantsReport2024-03-312025-03-3003958441ns10:SmallCompaniesRegimeForDirectorsReport2024-03-312025-03-3003958441ns10:SmallCompaniesRegimeForAccounts2024-03-312025-03-3003958441ns10:FullAccounts2024-03-312025-03-300395844112024-03-312025-03-3003958441ns10:OrdinaryShareClass12024-03-312025-03-3003958441ns10:RegisteredOffice2024-03-312025-03-3003958441ns5:CurrentFinancialInstruments2025-03-3003958441ns5:CurrentFinancialInstruments2024-03-3003958441ns5:ShareCapital2025-03-3003958441ns5:ShareCapital2024-03-3003958441ns5:RetainedEarningsAccumulatedLosses2025-03-3003958441ns5:RetainedEarningsAccumulatedLosses2024-03-3003958441ns5:LandBuildings2024-03-312025-03-3003958441ns5:PlantMachinery2024-03-312025-03-3003958441ns5:NetGoodwill2024-03-3003958441ns5:NetGoodwill2025-03-3003958441ns5:NetGoodwill2024-03-3003958441ns5:LandBuildings2024-03-3003958441ns5:PlantMachinery2024-03-3003958441ns5:LandBuildings2025-03-3003958441ns5:PlantMachinery2025-03-3003958441ns5:LandBuildings2024-03-3003958441ns5:PlantMachinery2024-03-3003958441ns5:WithinOneYearns5:CurrentFinancialInstruments2025-03-3003958441ns5:WithinOneYearns5:CurrentFinancialInstruments2024-03-3003958441ns5:WithinOneYear2025-03-3003958441ns5:WithinOneYear2024-03-3003958441ns5:BetweenOneFiveYears2025-03-3003958441ns5:BetweenOneFiveYears2024-03-3003958441ns5:AllPeriods2025-03-3003958441ns5:AllPeriods2024-03-3003958441ns5:DeferredTaxation2024-03-3003958441ns5:DeferredTaxation2024-03-312025-03-3003958441ns5:DeferredTaxation2025-03-3003958441ns10:OrdinaryShareClass12025-03-30
REGISTERED NUMBER: 03958441 (England and Wales)










UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 30 MARCH 2025

FOR

AWB LABORATORIES LIMITED

AWB LABORATORIES LIMITED (REGISTERED NUMBER: 03958441)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 MARCH 2025










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


AWB LABORATORIES LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 30 MARCH 2025







DIRECTOR: A W Barrs





REGISTERED OFFICE: Ground Floor
Egerton House
68 Baker Street
Weybridge
Surrey
KT13 8AL





REGISTERED NUMBER: 03958441 (England and Wales)





ACCOUNTANTS: RJP LLP
Ground Floor
Egerton House
68 Baker Street
Weybridge
Surrey
KT13 8AL

AWB LABORATORIES LIMITED (REGISTERED NUMBER: 03958441)

BALANCE SHEET
30 MARCH 2025

30.3.25 30.3.24
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 4 - -
Tangible assets 5 1,510 2,675
1,510 2,675

CURRENT ASSETS
Debtors 6 90,217 69,560
Cash at bank 23,420 47,255
113,637 116,815
CREDITORS
Amounts falling due within one year 7 24,867 31,211
NET CURRENT ASSETS 88,770 85,604
TOTAL ASSETS LESS CURRENT LIABILITIES 90,280 88,279

PROVISIONS FOR LIABILITIES 9 378 669
NET ASSETS 89,902 87,610

CAPITAL AND RESERVES
Called up share capital 10 2 2
Retained earnings 89,900 87,608
SHAREHOLDERS' FUNDS 89,902 87,610

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 March 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 March 2025 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 4 December 2025 and were signed by:




A W Barrs - Director


AWB LABORATORIES LIMITED (REGISTERED NUMBER: 03958441)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 MARCH 2025


1. STATUTORY INFORMATION

AWB Laboratories Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover represents the invoiced sale of goods and services, excluding Value Added Tax.

Revenue is recognised in the period in which goods and services are sold.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Land and buildings - 4% on cost
Plant and machinery etc - 25% on cost and 4% on cost

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 1 (2024 - 1 ) .

AWB LABORATORIES LIMITED (REGISTERED NUMBER: 03958441)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 MARCH 2025


4. INTANGIBLE FIXED ASSETS
Goodwill
£   
COST
At 31 March 2024
and 30 March 2025 58,863
AMORTISATION
At 31 March 2024
and 30 March 2025 58,863
NET BOOK VALUE
At 30 March 2025 -
At 30 March 2024 -

5. TANGIBLE FIXED ASSETS
Plant and
Land and machinery
buildings etc Totals
£    £    £   
COST
At 31 March 2024 49,475 64,363 113,838
Additions - 1,361 1,361
At 30 March 2025 49,475 65,724 115,199
DEPRECIATION
At 31 March 2024 47,691 63,472 111,163
Charge for year 1,784 742 2,526
At 30 March 2025 49,475 64,214 113,689
NET BOOK VALUE
At 30 March 2025 - 1,510 1,510
At 30 March 2024 1,784 891 2,675

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.3.25 30.3.24
£    £   
Other debtors 90,217 69,560

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.3.25 30.3.24
£    £   
Bank loans and overdrafts - 964
Taxation and social security 21,374 26,942
Other creditors 3,493 3,305
24,867 31,211

AWB LABORATORIES LIMITED (REGISTERED NUMBER: 03958441)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 MARCH 2025


8. LEASING AGREEMENTS

Minimum lease payments under non-cancellable operating leases fall due as follows:
30.3.25 30.3.24
£    £   
Within one year 4,546 4,546
Between one and five years 3,031 7,576
7,577 12,122

9. PROVISIONS FOR LIABILITIES
30.3.25 30.3.24
£    £   
Deferred tax 378 669

Deferred
tax
£   
Balance at 31 March 2024 669
Provided during year (291 )
Balance at 30 March 2025 378

10. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 30.3.25 30.3.24
value: £    £   
2 Ordinary £1.00 2 2

11. DIRECTOR'S ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 30 March 2025 and 30 March 2024:

30.3.25 30.3.24
£    £   
Director
Balance outstanding at start of year 68,928 65,229
Amounts advanced 104,271 79,013
Amounts repaid (83,681 ) (75,314 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 89,518 68,928

Interest has been charged on the loan to the director at a rate of 2.25% per annum.